LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 130 filers reported holding LOXO ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 2.66 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $251,226,000 | -18.9% | 1,793,587 | -1.1% | 0.06% | -3.1% |
| Q3 2018 | $309,682,000 | -2.1% | 1,812,811 | -0.6% | 0.06% | -7.1% |
| Q2 2018 | $316,425,000 | +39.5% | 1,823,983 | -7.2% | 0.07% | +37.3% |
| Q1 2018 | $226,810,000 | +28.8% | 1,965,936 | -6.0% | 0.05% | +30.8% |
| Q4 2017 | $176,117,000 | -22.9% | 2,092,151 | -15.6% | 0.04% | -25.0% |
| Q3 2017 | $228,285,000 | +16.2% | 2,478,130 | +1.2% | 0.05% | +13.0% |
| Q2 2017 | $196,447,000 | +91.5% | 2,449,765 | +0.5% | 0.05% | +84.0% |
| Q1 2017 | $102,587,000 | +76.1% | 2,437,872 | +34.4% | 0.02% | +66.7% |
| Q4 2016 | $58,262,000 | +39.0% | 1,814,142 | +13.3% | 0.02% | +36.4% |
| Q3 2016 | $41,928,000 | +40.4% | 1,601,534 | +24.3% | 0.01% | +37.5% |
| Q2 2016 | $29,858,000 | +120.9% | 1,288,106 | +160.5% | 0.01% | +100.0% |
| Q1 2016 | $13,518,000 | – | 494,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |